COVID-19: CDC, FDA and CMS Guidance
This page includes AHA Today stories and other AHA content on coronavirus COVID-19 guidance from the CDC, FDA, and CMS.
Weekly COVID-19-associated hospitalization rates among U.S. infants and children under age 5 have declined since peaking Jan. 8, but peak rates during omicron predominance were about five times those during delta predominance, the Centers for Disease Control and Prevention reported.
The Food and Drug Administration recently authorized extending from six to nine months the shelf life for refrigerated Johnson & Johnson COVID-19 vaccine stored at 2-8 degrees Celsius (about 36-46 degrees Fahrenheit), based on data submitted by the company.
The Transportation Security Administration will continue to require masks on public transportation through April 18 to protect against COVID-19, as the Centers for Disease Control and Prevention recommends.
In a study of 1,364 children aged 5-15, two doses of the Pfizer COVID-19 vaccine reduced the risk of omicron infection by 31% in those under 12 and 59% in older children, the Centers for Disease Control and Prevention reported.
Effective April 4, the Department of Health and Human Services will no longer require COVID-19 testing facilities to report negative results for tests authorized for use under a Clinical Laboratory Improvement Amendment certificate of waiver, the Centers for Disease Control and Prevention reports.
An estimated 28% of children aged 5-11 received a first dose of the Pfizer COVID-19 vaccine between Nov. 1 and Jan. 18, while 19% received a second dose, according to a report released by the Centers for Disease Control and Prevention
The Centers for Medicare & Medicaid Services has released a Medicare payment code effective Feb. 24 for administering the combination monoclonal antibody therapy Evusheld to prevent COVID-19 in certain patients.
The Centers for Disease Control and Prevention yesterday said more than 90% of the U.S. population now lives in a county with a low or medium COVID-19 Community Level, a new CDC measure for communities considering whether to require face coverings in public indoor settings.
The Food and Drug Administration yesterday alerted health care providers and the public to three COVID-19 antigen tests that are not authorized or approved for distribution or use in the United States.
The Centers for Disease Control and Prevention today announced a major adjustment of its federal masking guidance pertaining to the COVID-19 public health emergency, including changes to the metrics that communities are urged to use when determining whether to require face coverings in indoor…